Carbidopa News

Carbidopa currently has 3 news articles, with 10 predicted indications.

This page combines the AI-predicted indications for Carbidopa with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Original indication: Stalevo is indicated for the treatment of adult patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa / dopa-decarboxylase (DDC)-inhibitor treatment.
Evidence level: L5
Predicted indications (10):
- Rasmussen subacute encephalitis (98.4%)
- PLA2G6-associated neurodegeneration (97.6%)
- transaldolase deficiency (97.4%)
- myelitis (97.4%)
- fructose-1,6-bisphosphatase deficiency (97.1%)
- Lewy body dementia (96.0%)
- paralysis agitans, juvenile, of Hunt (95.6%)
- progressive supranuclear palsy-corticobasal syndrome (95.4%)
- X-linked intellectual disability-ataxia-apraxia syndrome (94.9%)
- X-linked intellectual disability-cerebellar hypoplasia syndrome (93.7%)